|
Murder convict gets parole over son’s heart ailment
Times of India NAGPUR: Considering the serious heart ailment of a murder convict’s son, the Nagpur bench of Bombay High Court granted him parole after his earlier application was rejected by the Amravati divisional commissioner. Achalpur resident Ashok Bhute’s parole … |
BULLETIN BOARD: March 26 – Wicked Local Plymouth
BULLETIN BOARD: March 26Wicked Local PlymouthThe Sacred Heart annual gala will be held at 6:30 p.m. Saturday, March 29, at the Indian Pond Country Club, located at 60 Country Club Way in Kingston. Enjoy a fun, festive … The chorus will be conducted b…
Follow the Blood – A Journey of a Blood Donation – Medgadget.com
|
Follow the Blood – A Journey of a Blood Donation
Medgadget.com Many of us have done transfusions as part of our clinical work, and we’ve donated blood ourselves, but what happens between donation and transfusion is more complicated than some may think. Here’s a fascinating video from City of Hope National Medical … |
Jahi McMath's Family to Be Honored by Terri Schiavo Network – NBC Bay Area
NBC Bay Area |
Jahi McMath’s Family to Be Honored by Terri Schiavo Network
NBC Bay Area While brain death and vegetative states are two different medical outcomes, both Jahi and Schiavo are now flashpoints for the country’s heated “end-of-life” debate. Friends Believe Jahi McMath, “Quiet Leader,” is Alive. The Oakland family thrust … |
Statins may help lung disease patients as well – Times of India
|
Statins may help lung disease patients as well
Times of India MUMBAI: Statins don’t only protect your heart, they could well help your lungs. Statins have in the last decade emerged as the most popular method to reduce cholesterol among patients. A new study from the University of Edinburgh —published in the … |
Shoemaker talks about daughter's death and organ donations – Hudson Star Observer
Hudson Star Observer |
Shoemaker talks about daughter’s death and organ donations
Hudson Star Observer He said many people think there are enough donors when you add the numbers, but many don’t realize that it takes unique circumstances surrounding the death. The victim has to die a certain way – usually brain death.” He said out of 100,000 deaths of … |
Ensayo indica Rituximab alivia la ansiedad en pacientes con linfoma folicular – Terra Argentina
|
Ensayo indica Rituximab alivia la ansiedad en pacientes con linfoma folicular
Terra Argentina En un ensayo clínico, la terapia de mantenimiento con rituximab redujo la ansiedad asociada con el cáncer frente a la espera vigilada en pacientes sin síntomas con linfoma folicular “no voluminoso” avanzado. El fármaco también difirió la necesidad de … |
Ensayo indica Rituximab alivia la ansiedad en pacientes con linfoma folicular – Terra Perú
|
Ensayo indica Rituximab alivia la ansiedad en pacientes con linfoma folicular
Terra Perú En un ensayo clínico, la terapia de mantenimiento con rituximab redujo la ansiedad asociada con el cáncer frente a la espera vigilada en pacientes sin síntomas con linfoma folicular “no voluminoso” avanzado. El fármaco también difirió la necesidad de … |
FDA Staff Recommends Rejection of Novartis Heart-Failure Drug – Wall Street Journal
|
FDA Staff Recommends Rejection of Novartis Heart-Failure Drug
Wall Street Journal The FDA’s medical review said the data didn’t show serelaxin slowed progress of heart failure nor did it “provide persuasive evidence of an effect” on shortness of breath, a main heart-failure symptom. The unusually negative review from FDA staff doesn … |
UPDATE 2-FDA staff review recommends against Novartis heart failure drug – Reuters
News Tonight Africa |
UPDATE 2-FDA staff review recommends against Novartis heart failure drug
Reuters “We recommend that serelaxin not be approved at this time because there is insufficient evidence to support the proposed indication to “improve the symptoms of acute heart failure through reduction of the rate of worsening of heart failure,” the … FDA Reviewers Recommend Against Approval For Novartis Heart Failure DrugForbes FDA Staff Recommends Rejection of Novartis Heart-Failure DrugWall Street Journal More bad news for Novartis on heart failure candidatePMLiVE GlobalPost all 28 news articles » |
